Evidence map›Paper›PMID 40710189›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Jiamin Chen, Xiaoman Kang, Xinghuan Ding, Yuyang Dai, Lei Sun, Man Li, Ting Liu, Enshan Feng, Xingang Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiamin ChenDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xiaoman KangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Xinghuan DingDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yuyang DaiNational Institute for Drug Clinical Trial, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.ORCID 0000-0003-1679-1508
Lei SunDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Man LiDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Ting LiuDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.ORCID 0000-0002-8030-018X
Enshan FengDepartment of Neurosurgery, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xingang ZhouDepartment of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Funding

Beijing Municipal Administration of Hospitals Incubating Program PX‑2023062Beijing Municipal Administration of Hospitals Incubating Program PX‑2024065Bridge Science Fundation of Beijing Ditan Hospital DTQL-202404
6 · The paper itself

Abstract

Primary central nervous system lymphoma (PCNSL) refers to non-Hodgkin lymphoma (NHL) originating in the brain, eyes, spinal cord, and cerebrospinal fluid without the presence of lymphoma outside of the central nervous system [...].

Indexed as

B7-H1 AntigenCentral Nervous System NeoplasmsHIV InfectionsLymphoma, Non-HodgkinFemaleHumansMaleMiddle AgedPrognosisB7-H1 AntigenCD274 protein, humanfluorescence in situ hybridizationHIVimmunohistochemistryPDL1primary central nervous system lymphoma

Identifiers

PMID40710189
PMCPMC12294013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.